Results

Total Results: 1,528 records

Showing results for "drugs".

281. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the four topics for which (1) preliminary phase III data for drugs or

282. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol

283. Association Between Outcomes and Dental Services in People With Substance Use Disorder: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/outcomes-dental-services-rapid-research.pdf
     May 01, 2025 - treatment, including but not limited to transmucosal (sublingual/buccal) buprenorphine and psychotropic drugs … condition characterized by the inability to control the use of substances such as legal or illegal drugs … SUD can result from the use of 10 separate classes of drugs: alcohol, caffeine, cannabis, hallucinogens … , anti-diarrheal drugs, antidepressants, stimulants, alcohol, cannabis, tobacco/nicotine; healthcare … Effective Prevention and Treatment of Substance Use Disorders Involving Illicit and Prescription Drugs

284. Making Healthcare Safer IV_Rapid Response_Deprescribing To Reduce Medication Harms in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-deprescribing.pdf
     February 01, 2024 - Drugs Aging. 2013 Oct;30(10):793- 807. doi: 10.1007/s40266-013-0106-8. PMID: 23912674. 11. … Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials. … Drugs Aging. 2019 Dec;36(12):1097-110. doi: 10.1007/s40266-019-00717-1. PMID: 31598908. … Withdrawal of antihypertensive drugs in older people. … Drugs Aging. 2013 Oct;30(10):793-807. doi: 10.1007/s40266-013-0106-8. PMID: 23912674.

285. Gout Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
     March 01, 2016 - Table A lists the drugs used to treat gout and notes the ones covered in this systematic review. … formulation Numerous Colchicine/ColcrysTM, Colchicine tablets, USP authorized generic Takeda Pharmaceuticals … None of the trials described in these information packets was included in this report, as the drugs … Non-steroidal anti-inflammatory drugs for acute gout. Cochrane Database Syst Rev. 2014;9:CD010120. … Noncompliance with arthritis drugs: magnitude, correlates, and clinical implications.

286. pneumonia-antibiotic-treatment-protocol-130718 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
     July 19, 2013 - significantly for patients with HAP.3-6 Optimal treatment involves choosing the right drug or combination of drugs … For drugs with a narrow therapeutic index, such as vancomycin and the aminoglycosides, the risk of toxicities … also reduce nephrotoxicity in patients who are receiving aggressive dosing, concurrent nephrotoxic drugs … discussion, a new KQ was added to examine the effect of using prolonged or continuous infusions of drugs … creatinine clearance, time above MIC, and ratio of AUC to MIC (see Table 1 below for drug classes and drugs

287. Psoriasis-Chronic Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
     November 01, 2012 - patients with widespread disease.4,8,9 Biologic therapies for psoriasis use genetically engineered drugs … Comparisons of drugs within each class was beyond the scope of this report. … Please see the glossary for a listing of drugs considered within each class. … results was conducted on www.clinicaltrials.gov and associated FDA regulatory documents for these drugs … J Drugs Dermatol. 2007;6:424-427. PMID: 17668540. 12 AHRQ Pub.

288. Making Healthcare Safer IV Rapid Review: Supply Chain Disruption Monitoring Programs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research.pdf
     April 01, 2025 - effective are patient safety practices (PSPs) for identifying and monitoring critical supplies and drugs … Management of drugs supply shortages in a hospital. … Antibiotic waste in a pediatric healthcare system: Wasting drugs that are in limited supply. … Drugs Ther Perspect. 2021;37(12):599-606. doi: 10.1007/s40267-021-00880-9. … Investigation of the group purchasing structure in the field of pharmaceuticals and medical devices

289. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
     March 08, 2012 - Six classes of drugs and nasal saline are used to treat SAR. … Several drugs have more than one route of administration (e.g., intranasal and oral), as described below … Plasma concentrations of these drugs are increased by cytochrome P450 inhibitors, such as macrolide … Drugs that were effective before pregnancy may be effective during pregnancy, but their use may be … Drugs used to treat SAR are pregnancy category B (presumed safe based on animal studies but without

290. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_2012-12-11.pdf
     January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The table below lists the three topics for which (1) preliminary phase III data were available for drugs

291. Ch 8-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_8-user-guide-to-ocer_130129.pdf
     October 01, 2013 - claims data Information EHRs Administrative Claims Prescriptions ordered Yes No Pharmacy data (drugs … The NDC is a unique, 10-digit, 3-segment number that is a standard product identifier for human drugs … Claims submitted to insurance companies for payment for drugs are submitted with the NDC code as well … The researchers identified differential adherence to antihypertensive drugs, which has implications … Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly

292. CARDIOVASCULAR (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Cambridge (MA): Aegerion Pharmaceuticals, Inc.; 2012 Dec. 12 p. … Cambridge (MA): Aegerion Pharmaceuticals, Inc.; 2013 Apr. 12 p.

293. Comparative Effectiveness Review No. 234 Evidence Summary: Management of Primary Headaches in Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-234-headaches-pregnancy-summary.pdf
     November 01, 2020 - Given the heightened sensitivity about the potential impact of drugs on the fetus or infant, there is … Treatment—triptans, ergot products, nonsteroidal anti-inflammatory drugs (NSAIDs: naproxen), and antihistamines

294. Functional-Limitations-Horizon-Scan-High-Impact-1306 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Drugs Today. 2010;46(1):49-67. 3. Sorbera LA, Dulsat C, Rosa E. … East Hanover (NJ): Novartis Pharmaceuticals Corporation; 2012 May. 22 p. … Drugs Future. 2010;35(2):93-7. … Also available: http://blue.regence.com/trgmedpol/drugs/dru256. pdf. 46.

295. Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
     April 01, 2022 - Conclusions A systematic review and two subsequent surveillance updates have found nonopioid drugs … Nonopioid drugs were associated with increased risk of class-specific harms (e.g., gastrointestinal … vivo effects of nonselective, partially selective, and selective non steroidal anti- inflammatory drugs … Interventions • Oral pharmacologic agents: nonsteroidal anti-inflammatory drugs, acetaminophen, muscle … Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and

296. Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacological Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
     April 15, 2021 - there should be harms data and lumping benzodiazepines with other sedatives (e.g., barbiturates, Z-drugs … We have added information on these drugs to the overview bullets. … This now reads: “for both drugs, we found evidence bases with two or more randomized controlled trials … Within each type of drug, it would be helpful to list the drugs alphabetically according to the generic … Many of the drugs do have a commonly recognized brand name that is not included in parentheses in the

297. Nephropathy-Contrast-Induced Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
     October 01, 2013 - converting-enzyme) inhibitors, angiotensin II receptor blockers, or non-steroidal anti- inflammatory drugs … Recent publications have questioned the role of N- acetylcysteine (NAC),8 withdrawal of nephrotoxic drugs … , ACE inhibitors, angiotensin II receptor blockers, diuretics, and non-steroidal anti-inflammatory drugs … we will explore the FDA AERS database for reported adverse events attributed to contrast media or drugs … Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.

298. Disposition of Comments for CER 211: Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
     December 20, 2018 - Summary Page 17, lines 49-51: how do you balance the higher efficacy with a burden of multiple drugs … ).1 To account for the difference scales, we are using SMDs as our effect size comparing different drugs … We have modified the text to incorporate the same subject (drugs) into the first and last sentence. … When evaluated in head to head comparison with other drugs, it would be really valuable for patients … In some comparisons of csDMARDS, and other drugs, there are also multiple studies.

299. Clopidogrel after Drug-Eluting Stent Implantation: Is current practice sufficient (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
     March 01, 2009 - the Agency for Healthcare Research and Quality, Proctor and Gamble, Pfizer, Medtronic, Alexion Pharmaceuticals … , Medicure, Medtronic Vascular, Bristol-Myers Squibb, and Novartis Pharmaceuticals. … Institute, the Agency for Healthcare Research and Quality, Proctor & Gamble, Pfizer, Medtronic, Alexion Pharmaceuticals

300. Antipsychotics-Adults Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_surveillance.pdf
     August 30, 2014 - The British Medical Journal 2 Clinical Neuropharmacology 2 Current Opinion in CPNS Investigational Drugs … adj3 bipolar).tw. 128 31 or/22-30 34791 32 or/21,31 127425 33 or/16,32 230151 34 exp Neuroleptic Drugs … Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments … participants) from Jan 1, 1980, to Nov 25, 2010, which compared any of the following pharmacological drugs … INTERPRETATION: Overall, antipsychotic drugs were significantly more effective than mood stabilisers